Nuclear Investing Podcast

Episode 3 of our Texas Nuclear Summit series, recorded on location in Houston at the summit hosted by the Texas Nuclear Alliance.Brennan Moore sits down with John Arnold, Co-Founder & Co-Chair of Arnold Ventures, and Reed Clay, Founder & President of the Texas Nuclear Alliance, right after their panel at the summit.They get into what nuclear can learn from the public backlash to data centers, why community buy-in has to start before a project arrives, where nuclear sits on the Gartner Hype Cycle, whether the US needs to build another large-scale reactor, the brownfield opportunity at Comanche Peak and South Texas Project, and how John thinks about allocating to nuclear today.

“...anyone with three traits is most exposed right now, and that’s long duration, cash burning, financing-dependent businesses.”Brennan Moore, CFA and Andrew Meehan of Neutron Power Ventures break down the sell-off in nuclear stocks, which names have held up, and how the project-level SPV behind CoreWeave’s financing (“the box”) shows up in nuclear projects too.Also in this episode- Why this downturn could quickly filter the field of reactor developers into winners and losers- Public vs private: where nuclear companies should raise right now, and where investors may find better value- The pro rata rights dispute between Valar Atomics and early investor Day One Ventures, and why choosing aligned partners matters- X-energy’s 960 MW joint development agreement with Amazon and AEP- The Nuclear Company’s 6.6 GW AP1000 proposal in Kentucky, and EDF financing vs regulatory reform- NRC renews the AP1000 design certification through 2066- Kairos Power raises $643mm for Hermes 2- Urenco’s enrichment expansion, and incumbents vs new entrants like General Matter#NuclearEnergy #SMR #CleanTechInvesting #EnergyTransition #PublicMarkets #NuclearFinance

"We're building new nuclear by uprating our existing fleet."Brennan Moore, CFA and Andrew Meehan of Neutron Power Ventures break down the week of the uprates: Amazon/Constellation, Google/Constellation, and Vistra's conditional loan from DOE's Office of Energy Dominance Financing (EDF), with a hyperscaler behind each one.Also in this episode:- Why uprates are the most efficient means of near-term nuclear deployment- Korea's U.S. nuclear commitment (up to $120bn): six AP1000s and two APR1400s- Why cost is nuclear's biggest hurdle in the West- Why capital keeps flowing to early-stage advanced reactors in private markets- BWRX-300 vs. first-of-a-kind advanced reactors on $/kW, plus TVA's Clinch River permit- General Matter applies for an NRC license- Community buy-in, Antares' NASA award, and momentum abroad

Episode 2 of our Texas Nuclear Summit series, recorded on location in Houston and hosted by the Texas Nuclear Alliance.Brennan Moore sits down with Jordan Robison, P.E., Chief Executive Officer of Natura Resources. Natura is building the MSR-1, a molten salt demonstration reactor at Abilene Christian University, and designing the MSR-100 to deliver power, clean water from oil field produced water, and medical isotopes from a single reactor.We get into Abilene's data center boom, how Natura approached NRC licensing, why liquid fuel and low pressure open up new use cases for nuclear, fuel strategy beyond HALEU, the State of Texas's $120mm appropriation for the demonstration project, and the private vs public capital question facing advanced nuclear companies.

Episode 1 of our Texas Nuclear Summit series, recorded on location in Houston and hosted by the Texas Nuclear Alliance.In this episode of the Nuclear Investing Podcast, host Brennan Moore sits down with frequent guest Andrew Meehan to discuss key trends across nuclear technology, financing, and market strategy. They explore recent corporate developments—including Holtec's withdrawn IPO and the Bechtel–TerraPower split—and analyze why cost of capital, execution risk, and time horizons hinder gigawatt-scale deployments. Andrew recaps his visit to Texas A&M's RELLIS Campus and TRIGA research reactor, explaining the mechanics and high-value applications of targeted alpha therapy medical isotopes. They get into military and space applications for nuclear and the idea of the government as an ideal first customer. They also cover what's happening on the ground at the Texas Nuclear Summit and much more.